A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 4, 2011, Pages 855-858

  van der Donk, C F M ^a   Beisser, P S ^a   Hoogkamp Korstanje, J A A ^a   Bruggeman, C A ^a,b   Stobberingh, E E ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

lactam antibiotics; Enterobacteriaceae; ESBLs; Fluoroquinolones

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEMASE; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOODSTREAM INFECTION; BROTH DILUTION; ENZYME SYNTHESIS; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; URINARY TRACT INFECTIONS;

EID: 79952778339     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq538     Document Type: Article

References (9)

1. Jones ME, Draghi DC, Thornsberry C et al. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004; 3: 14.
2. Stichting Werkgroep Antitbioticabeleid. Antibioticaboekje. http://customid.duhs.duke.edu/NL/Main/Start.asp (30 November 2010, date last accessed).
3. Stichting Werkgroep Antibioticabeleid. NETHMAP 2008: Consumption of Antimicrobial Agents and Antimicrobial Resistance Among Medically Important Bacteria in the Netherlands. http://www.swab.nl/swab/cms3.nsf/uploads/6E11368E7BB72739C12575940049664D/$FILE/NethMap_2008.pdf (1 December 2010, date last accessed).
4. The European Committee on Antimicrobial Susceptibility Testing. EUCAST Clinical Breakpoint Table v. 1.1 2010-04-27. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.1.xls (1 December 2010, date last accessed).
5. Nederlandse Vereniging voor Medische Microbiologie. Richtlijn voor screening en confirmatie van extended-spectrum-beta-lactamase (ESBLs) in Enterobacteriaceae. http://www.nvmm.nl/richtlijnen/esblscreening-en-confirmatie (1 December 2010, date last accessed).
6. CDC. Modified Hodge Test for Carbapenemase Detection in Enterobacteriaceae. http://www.ndhealth.gov/microlab/Uploads/HodgeTest.pdf (1 December 2010, date last accessed).
7. Vogelaers D, De Bels D, Foret F et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates-a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 2010; 35: 375-81.
8. Sturm PD, Bochum ET, van Mook-Vermulst SV et al. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum β-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microb Drug Resist 2010; 16: 55-60.
9. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.